Your browser doesn't support javascript.
loading
BRAF inhibitor (vemurafenib) concurrent with radiation therapy for metastatic melanoma producing severe skin and oral cavity reactions.
Wallach, Jonathan B; Rietschel, Petra; Kalnicki, Shalom; Fox, Jana L.
Afiliação
  • Wallach JB; Department of Radiation Oncology, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, New York.
  • Rietschel P; Department of Medical Oncology, Bayer Hospital, Wayne, New Jersey.
  • Kalnicki S; Department of Radiation Oncology, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, New York.
  • Fox JL; Department of Radiation Oncology, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, New York. Electronic address: jfox@montefiore.org.
Pract Radiat Oncol ; 4(5): e213-e216, 2014.
Article em En | MEDLINE | ID: mdl-25194107

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / Sulfonamidas / Neoplasias Encefálicas / Quimiorradioterapia / Indóis / Melanoma / Doenças da Boca Limite: Aged80 / Female / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / Sulfonamidas / Neoplasias Encefálicas / Quimiorradioterapia / Indóis / Melanoma / Doenças da Boca Limite: Aged80 / Female / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article